Chance, nécessité, et naïveté ingredients to create a new organizational form

The Emergence of Organizations and Markets

Volumn , Issue , 2012, Pages 379-433

  Powell, Walter W ^a   Sandholtz, Kurt ^b,c  

^a STANFORD UNIVERSITY   (United States)

^b Stanford's Center for Work Technology and Organization ^*  (United States)

^c BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883942914     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (171)

1. Aldrich, Howard E., and C. Marlene Fiol. 1994. "Fools Rush In? The Institutional Context of Industry Creation." Academy of Management Review 19(4):645-70.
2. Anderson, Phillip M., and Michael Tushman. 1990. "Technological Discontinuities and Dominant Designs: A Cyclical Model of Technological Change." Administrative Science Quarterly 35(4):604-33.
3. Baron, J. N., M. T. Hannan, and M. D. Burton. 1999. "Building the Iron Cage: Determinants of Managerial Intensity in the Early Years of Organizations." American Sociological Review 64(4):527-47.
4. Baker, Ted, and Reed E. Nelson. 2005. "Creating Something from Nothing: Resource Construction through Entrepreneurial Bricolage." Administrative Science Quarterly 50:329-66.
5. Becker, Howard S. 1963. Outsiders: Studies in the Sociology of Deviance. Glencoe, IL: The Free Press.
6. Becker, Howard S. 1986. Doing Things Together. Evanston, IL: Northwestern University Press.
7. Beckman, Christine M., and M. Diane Burton. 2008. "Founding the Future: Path Dependence in the Evolution of Top Management Teams from Founding to IPO." Organization Science 19(1):3-24.
8. Berkley, James D., and Nitin Nohria. 1992. "Amgen Inc.: Planning the Unplannable." Harvard Business School Case #9-492- 052. Boston: Harvard Business School Publishing.
9. Berman, Elisabeth Popp. 2007. "Creating the Market University: Science, the State, and the Economy, 1965-1985." Ph.D. diss., UC-Berkeley.
10. Binder, Gordon, and Philip Bashe. 2008. Science Lessons: What the Business of Biotech Taught Me about Management. Boston: Harvard Business School Press.
11. Biogen IDEC. 2003. "Biogen and IDEC Pharmaceuticals Announce Merger to Create a New Biotechnology Industry Leader." Press release, June 23. Blumer, Herbert. 1969. Symbolic Interactionism: Perspective and Method. Englewood Cliffs, NJ: Prentice-Hall.
12. Boyer, Herbert W. 2001. "Recombinant DNA Research at UCSF and Commercial Application at Genentech." Oral history conducted in 1994 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
13. Burrill, Stephen G. 2007. "Biotech 2007: A Retrospective Look and a Vision for Its Future." Paper presented at Chemical Heritage Foundation, April 19.
14. Burt, Ronald S. 2009. Neighbor Networks. Oxford: Oxford University Press.
15. Burton, M. Diane, J. B. Sorensen, and C. Beckman. 2002. "Coming from Good Stock: Career Histories and New Venture Formation." In Research in the Sociology of Organizations, vol. 19, ed. M. Lounsbury and M. Ventresca, 229-62. Greenwich, CT: JAI Press.
16. Byers, Brook. 2006. "Brook Byers: Biotechnology Venture Capitalist, 1970-2006." Oral history conducted in 2002-5 by Thomas D. Kiley, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
17. Bylinski, G. 1980. "DNA Can Build Companies, Too." Fortune, June 16, pp. 144-53.
18. Cape, Ronald. 2006. "Biotech Pioneer and Co-Founder of Cetus." Oral history conducted in 2003 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
19. Carroll, G. R., L. S. Bigelow, M-D. L. Seidel, and L. B. Tsai. 1996. "The Fates of de novo and de alio Producers in the American Automobile Industry, 1885- 1981." Strategic Management Journal 17:117-37.
20. Centocor. 1982. Annual Report to Shareholders. Copy in possession of the authors.
21. Chatterji, A. K. 2009. "Spawned with a Silver Spoon? Entrepreneurial Performance and Innovation in the Medical Device Industry." Strategic Management Journal 30(2):185-206.
22. Chemical Heritage Foundation. 1997. "The Emergence of Biotechnology: DNA to Genentech." Transcript of June 13 conference.
23. Christensen, C., and R. S. Rosenbloom. 1995. "Explaining the Attacker's Advantage: Technological Paradigms, Organizational Dynamics and the Value Network." Research Policy 24:233-57.
24. Cicourel, Aaron. 1968. The Social Organization of Juvenile Justice. New York: John Wiley.
25. Clarke, Adele C. 1991. "Social Worlds/Arenas Theory as Organizational Theory." In Social Organization and Social Processes: Essays in Honor of Anselm L. Strauss, ed. David Maines, 119-58. New York: Aldine.
26. Cockburn, Iain M., and Scott Stern. 2010. "Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Technology Policy." Capitalism and Society 5(1), Article 1, available at: http://www.bepress.com/cas/vol5/iss1/art1.
27. Cockburn, Iain M., Rebecca M. Henderson, and Scott Stern. 2000. "Untangling the Origins of Competitive Advantage." Strategic Management Journal 21(10/11):1123-45.
28. Cohen, Stanley. 1975. "The Manipulation of Genes." Scientific American 233(1):24-33.
29. Cohen, S. N., A.C.Y. Chang, H. W. Boyer, and R. B. Helling. 1973. "Construction of Biologically Functional Bacterial Plasmids in Vitro." Proceedings of the National Academy of Sciences 70:3240-44.
30. Colyvas, Jeannette. 2007a. "Factory, Hazard, and Contamination: The Use of Metaphor in the Commercialization of Recombinant DNA." Minerva 45(2):143-59.
31. Colyvas, Jeannette. 2007b. "From Divergent Meanings to Common Practices: The Early Institutionalization of Technology Transfer at Stanford University." Research Policy 36(4):456-76.
32. Colyvas, Jeannette, and W. W. Powell. 2006. "Roads to Institutionalization." Research in Organizational Behavior 21:305-53.
33. Colyvas, Jeannette. 2007. "From Vulnerable to Venerated: The Institutionalization of Academic Entrepreneurship in the Life Sciences." Research in the Sociology of Organizations 25:345-73.
34. D'Andrade, Hugh A. 2001. "Regional Characteristics of Biotechnology in the United States: Perspectives of Three Industry Leaders." Oral history conducted in 1998 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
35. Dewey, John. 1939. Theory of Valuation. Chicago: University of Chicago Press.
36. Dietrich, Heidi. 2003. "Amgen Shrinks Seattle Operations." Los Angeles Business Journal, May 5.
37. Duncan, David E. 2005. The Amgen Story: 25 Years of Visionary Science and Powerful Medicine. San Diego, CA: Tehabi Books.
38. Duzan, Steve. 2009. Phone interview by Kurt Sandholtz, September 24.
39. Eisenhardt, Kathleen M., and Melissa E. Graebner. 2007. "Theory Building from Cases: Opportunities and Challenges." Academy of Management Journal 50(1):25-32.
40. Elkington, John. 1985. The Gene Factory. New York: Carroll and Graf.
41. Feder, Barnaby J. 1991. "Biotech's Biggest Sales So Far Are on Wall Street." New York Times, November 3, sec. 3, p. 12.
42. Elkington, John. 1992. "Biogen Seeks Profits to Call Its Own." New York Times. August 15.
43. Fikes, Bradley J 1999. "Why San Diego Has Biotech." San Diego Metropolitan, April. Available at http://sandiegometro.archives.whsites.net/1999/apr/biotech.html.
44. Fisher, Lawrence M. 1997. "The Rocky Road from Start-up to Big-T ime Player: Biogen's Triumph against the Odds." Strategy + Business, July. Third Quarter 1997. Available at http://www.strategy-business.com/press/article/18003.
45. Fleming, Lee. 2001. "Recombinant Uncertainty in Technological Search." Management Science 47(1):117-32. Fletcher, Liz. 2002. "Amgen's Big-T icket Play for Immunex." Nature Biotechnology 20:105-6.
46. Fletcher, Liz. 2002. "Amgen's Big-T icket Play for Immunex." Nature Biotechnology 20:105-6.
47. Fligstein, Neil. 2001. "Social Skill and the Theory of Fields." Sociological Theory 19:105-25.
48. Fredrickson, Donald N. 2001. The Recombinant DNA Controversy: A Memoir. Washington, DC: ASM Press.
49. Freeman, John, Glenn R. Carroll, and Michael T. Hannan. 1983. "The Liability of Newness: Age Dependence in Organizational Death Rates." American Sociological Review 48(5):692-710.
50. Fujimura, Joan H. 1987. "Constructing 'Do-Able' Problems in Cancer Research: Articulating Alignment." Social Studies of Science 17(2):257-93.
51. Gambardella, Alfonso. 1995. Science and Innovation: The U.S. Pharmaceutical Industry during the 1980s. New York: Cambridge University Press.
52. Gannes, Stuart. 1987. "Striking It Rich in Biotech." Fortune 116(11):9.
53. Garfinkel, Harold. 1967. Studies in Ethnomethodology. Englewood Cliffs, NJ: Prentice Hall.
54. "Genex Chief Steps Down." 1987. New York Times, January 6, p. D2.
55. Genzyme. 1986. Preliminary Prospectus dated April 16. In possession of the authors.
56. Gibbons, Ann. 1989. "The Man Who Made Millions by Marketing Monoclonal Antibodies." The Scientist 3(5).
57. Gillis, Steven. 2009. Phone interview by Kurt Sandholtz, October 1.
58. Glaser, Donald. 2006. "The Bubble Chamber, Bioengineering, Business Consulting, and Neurobiology." Oral history conducted in 2003-4 by Eric Vettel, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
59. Glassmeyer, Edward. 2009. Phone interview by Kurt Sandholtz, August 10.
60. Glick, J. Leslie. 2009. Phone interview by Kurt Sandholtz, September 9.
61. Goeddel, David V. 2003. "Scientist at Genentech, CEO at Tularik." Oral history conducted in 2001 and2002 by Sally Smith Hughes for the Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
62. Goffman, Erving. 1974. Frame Analysis. Cambridge, MA: Harvard University Press.
63. Gompers, Paul A. 1994. "The Rise and Fall of Venture Capital." Business and Economic History 23(2):1-26.
64. Gould, Stephen Jay, and Elisabeth S. Vrba. 1982. "Exaptation: A Missing Term in the Science of Form." Paleobiology 8(1):4-15.
65. Graham, Margaret B. W. 2008. "Technology and Innovation." In The Oxford Handbook of Business History, ed. Geoffrey Jones and Jonathan Zeitlin, 347-73. New York: Oxford University Press.
66. Green, William G. 2008. "William G. Green: General Counsel Chiron Corporation." Oral history conducted in 2005 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
67. Hall, Stephen S. 1987. Invisible Frontiers: Race to Synthesize a Human Gene. New York: Atlantic Monthly Press.
68. Hargadon, Andrew, and Robert I. Sutton. 1997. "Technology Brokering and Innovation in a Product Development Firm." Administrative Science Quarterly 42(4):716-49.
69. Helfat, Connie E., and Marvin B. Lieberman. 2002. "The Birth of Capabilities: Market Entry and the Importance of Pre-History." Industrial and Corporate Change 11(4):725-60.
70. Henderson, Rebecca. 1993. "Underinvestment and Incompetence as Responses to Radical Innovation: Evidence from the Photolithographic Alignment Equipment Industry." RAND Journal of Economics 24(2):248-70.
71. Henderson, Rebecca, and K. B. Clark. 1990. "Architectural Innovation: The Reconfiguration of Existing Product Technologies and the Failure of Established Firms." Administrative Science Quarterly 35(1):9-30.
72. Higgins, Monica. 2005. Career Imprints: How the Baxter Boys Built the Biotech Industry. San Francisco: John Wiley.
73. Holveck, David P. 2001. "Regional Characteristics of Biotechnology in the United States: Perspectives of Three Industry Insiders." Oral history conducted in 1998 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
74. Hounshell, David A. 1996. "The Evolution of Industrial Research in the United States." In Engines of Innovation: U.S. Industrial Research at the End of an Era, ed. Richard S. Rosenbloom and William J. Spencer, 13-85. Boston: Harvard Business School Press.
75. Hughes, Sally Smith. 2001. "Making Dollars out of DNA: The First Major Patent in Biotechnology and the Commercialization of Molecular Biology, 1974-1980." Isis 92(3):541-75.
76. Hybels, Ralph C. 1994. "Legitimation, Population Density and Founding Rates: The Institutionalization of Commercial Biotechnology in the U.S., 1971-89." Ph.D. diss., Cornell University.
77. Hybritech. 1981. Prospectus for Initial Public Offering. In possession of the authors.
78. Immunex. 2001. "Amgen to Acquire Immunex for $16 Billion in Stock and Net Cash." Immunex press release, December 17.
79. Jackson, David A. 2009. Phone Interview by Kurt Sandholtz, October 5.
80. Jackson, D. A., R. H. Symons, and P. Berg. 1972. "Biochemical Methods for Inserting New Genetic Information into DNA of Simian Virus 40: Circular SV 40 DNA Molecules Containing Lambda Phage Genes and the Galactose Operon of Escherichia Coli." Proceedings of the National Academy of Sciences 69:2904.
81. JAI. 2009. "Robert A. Johnston." Biographical information posted on http://www.jaivc.com .
82. Johnson, Victoria. 2007. "What Is Organizational Imprinting? Cultural Entrepreneurship in the Founding of the Paris Opera." American Journal of Sociology 113(1):97-127.
83. Jones, Mark Peter. 2005. "Biotech's Perfect Climate: The Hybritech Story." Ph.D. diss., UC-San Diego.
84. Jong, Simcha. 2008. "Academic Organizations and New Industrial Fields: Berkeley and Stanford after the Rise of Biotechnology." Research Policy 37(8):1267-82.
85. Kaplan, Sarah, and Mary Tripsas. 2008. "Thinking about Technology: Applying a Cognitive Lens to Technical Change." Research Policy 37(5):790-805.
86. Kenney, Martin. 1986a. Biotechnology: The University-Industrial Complex. New Haven, CT: Yale University Press.
87. Kenney, Martin. 1986b. "Schumpeterian Innovation and Entrepreneurs in Capitalism: The Case of the U.S. Biotechnology Industry." Research Policy 15(4):21-31.
88. Kenney, Martin, and Richard Florida. 2000. "Venture Capital in Silicon Valley: Fueling New Firm Formation." In Understanding Silicon Valley: The Anatomy of an Entrepreneurial Region, ed. Martin Kenney, 98-123. Stanford: Stanford University Press.
89. Kevles, Daniel J. 1994. "Diamond v. Chakrabarty and Beyond: The Political Economy of Patenting Life." In Private Science: Biotechnology and the Rise of Molecular Science, ed. Arnold Thackray, 65-79. Philadelphia: University of Pennsylvania Press.
90. Kiley, Thomas D. 2002. "Thomas D. Kiley: Genentech Legal Counsel and Vice President, 1976-1988, and Entrepreneur." Oral history conducted in 2000 and 2001 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
91. Klepper, Steve, and K. L. Simons. 2000. "Dominance by Birthright: Entry of Prior Radio Producers and Competitive Ramifications in the U.S. Television Receiver Industry." Strategic Management Journal 21:997-1016.
92. Klepper, Steve, and Sally Sleeper. 2005. "Entry by Spinoffs." Management Science 51(8):1291-1306.
93. Koberstein, Wayne. 1994. "Edward Penhoet." Pharmaceutical Executive 14(10):40-47.
94. Köhler, Georges, and Cesar Milstein. 1975. "Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity." Nature 256:495-97.
95. Kornberg, Arthur. 1995. The Golden Helix: Inside Biotech Ventures. Sausalito, CA: University Science Books.
96. Kornberg, Arthur. 1998. "Biochemistry at Stanford, Biotechnology at DNAX." Oral history conducted in 1997 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
97. Latour, Bruno. 1987. Science in Action. Cambridge, MA: Harvard University Press.
98. Law, John. 1984. "On Ships and Spices: Technology, Power and the Portuguese Route to India." Centre de Sociologie de l'Innovation, Ecole des Mines de Paris.
99. Levinson, Arthur D. 2001. Introduction to "Robert A. Swanson: Co-founder, CEO, and Chairman of Genentech, Inc., 1976-1996." Oral history conducted in 1996 and 1997 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
100. Longman, Roger. 1996. "ALZA Breaks Out of the Ivory Tower." In Vivo (January):44-52.
101. March, James G., and Herbert A. Simon. 1958. Organizations. New York: John Wiley and Sons.
102. McKelvey, Maureen D. 1996. Evolutionary Innovations: The Business of Biotechnology. Oxford: Oxford University Press.
103. McKendrick, David, and Glenn Carroll. 2001. "On the Genesis of Organizational Forms: Evidence from the Market for Disk Arrays." Organization Science 12(6):661-82.
104. Mead, George Herbert. 1934. Mind, Self and Society. Chicago: University of Chicago Press.
105. Molotch, Harvey. 2003. Where Stuff Comes From. New York: Routledge.
106. More, Ginger. 2009. Phone interview by Kurt Sandholtz, August 11.
107. Morrill, David. 2011. "Pharmaceutical Giant Novartis Emerges from the Shadows." Contra Costa Times, April 18.
108. Morrow, J. F., S. N. Cohen, A.C.Y. Chang, H. W. Boyer, H. M. Goodman, and R. B. Helling. 1974. "Replication and Transcription of Eukaryotic DNA in Escherichia coli." Proceedings of the National Academy of Sciences 71:1743-47.
109. Mowery, David, R. Nelson, Bhaven Sampat, and Arvids Ziedonis. 2004. Ivory Tower and Industrial Innovation. Stanford: Stanford University Press.
110. Nelson, Andrew J. 2007. "Institutional Convergence and the Diffusion of University-V ersus Firm-O rigin Technologies." Ph.D. diss., Stanford University.
111. Nelson, Richard R., and Sidney G. Winter. 1982. An Evolutionary Theory of Economic Change. Cambridge, MA: Belknap Press of Harvard University Press.
112. Oliver, Amalya L., and Kathleen Montgomery. 2000. "Creating a Hybrid Organizational Form from Parental Blueprints: The Emergence and Evolution of Knowledge Firms." Human Relations 53:33-56.
113. Orsenigo, Luigi. 1989. The Emergence of Biotechnology: Institutions and Markets in Industrial Innovation. London: Pinter.
114. Owen-S mith, Jason, and W. W. Powell. 2001. "Careers and Contradictions: Faculty Responses to the Transformation of Knowledge and Its Uses in the Life Sciences." Research in the Sociology of Work 10:109-40.
115. Padgett, John F., and Paul McLean. 2006. "Organizational Invention and Elite Transformation: The Birth of Partnership in Renaissance Florence." American Journal of Sociology 111(4):1463-1568.
116. Penhoet, Edward. 2001. "Regional Characteristics of Biotechnology in the United States: Perspectives of Three Industry Leaders." Oral history conducted in 1998 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
117. Perkins, Thomas J. 2002. "Kleiner Perkins, Venture Capital, and the Chairmanship of Genentech, 1976-1995." Oral history conducted in 2001 by Glenn E. Bugos, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
118. Pisano, Gary P. 2006. Science Business: The Promise, the Reality, and the Future of Biotech. Boston: Harvard Business School Press.
119. Porter, Kelley Anne. 2004. "You Can't Leave Your Past Behind: The Influence of Founders' Career Histories on Their Firms." Ph.D. diss., Stanford University.
120. Powell, Bonnie Azab. 1999. "Is Eight Enough? Howard Birndorf Can't Stop Starting Biotech Companies." Red Herring. September.
121. Powell, W. W. 1990. "Neither Market nor Hierarchy: Network Forms of Organization." Research in Organizational Behavior 12:295-336.
122. Powell, W. W. 1996. "Inter-organizational Collaboration in the Biotechnology Industry." Journal of Institutional and Theoretical Economics 120(1):197-215.
123. Powell, W. W., and Peter Brantley. 1996. "Magic Bullets and Patent Wars: New Product Development and the Evolution of the Biotechnology Industry." In Competitive Product Development, ed. Toshihiro Nishiguchi, 233-60. Oxford: Oxford University Press.
124. Powell, Walter W., Kenneth W. Koput, and Laurel Smith-Doerr. 1996. "Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology." Administrative Science Quarterly 41:116-45.
125. Powell, W. W., Douglas R. White, Kenneth W. Koput, and Jason Owen-S mith. 2005. "Network Dynamics and Field Evolution: The Growth of Interorganizational Collaboration in the Life Sciences." American Journal of Sociology 110:1132-1205.
126. Proctor, Richard. 2009. Interview conducted by Kurt Sandholtz.
127. Rabinow, Paul. 1996. Making PCR: A Story of Biotechnology. Chicago: University of Chicago Press.
128. Rao, Hayagreeva. 1998. "Caveat Emptor: The Construction of Nonprofit Consumer Watchdog Organizations." American Journal of Sociology 103(4): 912-61.
129. Rao, Hayagreeva, and Martin Kenney. 2008. "New Forms as Settlements." In The Sage Handbook of Organizational Institutionalism, ed. R. Greenwood, C. Oliver, K. Sahlin and R. Suddaby, 352-70. Thousand Oaks, CA: Sage Publications.
130. Rao, Hayagreeva, Calvin Morrill, and Mayer Zald. 2000. "Power Plays: How Social Movements and Collective Action Create New Organizational Forms." In Research in Organizational Behavior 22, ed. B. Staw and R. Sutton, 239-82. Greenwich, CT: JAI Press.
131. Rathmann, George B. 2004. "Chairman, CEO, and President of Amgen, 1980-1988." Oral history conducted in 2003 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
132. Reich, Leonard. 1985. The Making of American Industrial Research: Science and Business at GE and Bell, 1876-1926. New York: Cambridge University Press.
133. Reimers, Niels. 1987. "Tiger by the Tale." Chem Tech 17(8):464-71.
134. Rhoten, Diana, and W. W. Powell. 2007. "The Frontiers of Intellectual Property: Expanded Protection vs. New Models of Open Science." Annual Review of Law and Social Science 3:345-73.
135. Robbins-R oth, Cynthia. 2000. From Alchemy to IPO: The Business of Biotechnology. Cambridge, MA: Perseus Publishing.
136. Roberts. Edward B. 1991. Entrepreneurs in High Technology: Lessons from MIT and beyond. Oxford: Oxford University Press.
137. Royston, Ivor. 2006. Address given to the Von Leibig Forum, June 26, UCTV: University of California, San Diego. Available at http://www.uctv.tv/search -details. asp?showID=11752.
138. Rutter, William J. 1997. "The Emergence of Biotechnology: DNA to Genentech." Transcript of a presentation at the Chemical Heritage Foundation. Philadelphia, June 13.
139. Rutter, William J. 1998. "William J. Rutter, PhD." Oral history conducted in 1992 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
140. Saxenian, Annalee. 1994. Regional Advantage: Culture and Competition in Silicon Valley and Route 128. Cambridge, MA: Harvard University Press.
141. Schneiberg, Marc, and Michael Lounsbury. 2008. "Social Movements and Institutional Analysis." In The SAGE Handbook of Organizational Institutionalism, ed. Royston Greenwood, Christine Oliver, Roy Suddaby, and Kerstin Sahlin-Andersson, 650-72. Thousand Oaks, CA: Sage.
142. Schumpeter, Joseph. 1939. Business Cycles: A Theoretical, Historical, and Statistical Analysis of the Capitalist Process. New York: McGraw Hill.
143. Senior, Melanie. 2007. "Genzyme: Why Diversification Is Starting to Look Smart." In Vivo (December): 8-15.
144. Sewell, William F. 1992. "A Theory of Structure: Duality, Agency, and Transformation." American Journal of Sociology 98(1):1-29.
145. Shaw, Donna. 1997. "Innovator and Optimist at Centocor: Those in the Industry Call Him an Idea Man and a Mentor. And, He Says, 'I Never Gave Up Hope.'" Philadelphia Inquirer, April 2.
146. Snyder, Sheridan. 2009. E-mail interview by Kurt Sandholtz, August 20.
147. Stinchcombe, Arthur L. 1965. "Social Structure and Organizations." In Handbook of Organizations, ed. James G. March, 142-93. Chicago: Rand McNally.
148. Strauss, Anselm. 1978. Negotiations: Varieties, Contexts, Processes, and Social Order. San Francisco: Jossey-Bass.
149. Stuart, Toby E., and Waverly Ding. 2006. "When Do Scientists Become Entrepreneurs? The Social Structural Antecedents of Commercial Activity in the Academic Life Sciences." American Journal of Sociology 11:97-144.
150. Sudnow, David. 1965. "Normal Crimes: Sociological Features of the Penal Code in a Public Defender's Office." Social Problems 12(3):255-76.
151. Swanson, Robert A. 2001. "Robert A. Swanson: Co-founder, CEO, and Chairman of Genentech, Inc., 1976-1996." Oral history conducted in 1996 and 1997 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
152. Teitelman, Robert. 1985. "Searching for Serendipity: Centocor Combs University Labs for Technology." Forbes 135(10):80-81.
153. Teitelman, Robert. 1989. Gene Dreams: Wall Street, Academia and the Rise of Biotechnology. New York: Basic Books.
154. Timmerman, Luke. 2001. "Immunex Seeks Genie in a Bottle." Seattle Times, August 26.
155. Teitelman, Robert. 2004. "Life after Immunex." Seattle Times, August 30.
156. Tripsas, Mary. 1997. "Unraveling the Process of Creative Destruction: Complementary Assets and Incumbent Survival in the Typesetter Industry." Strategic Management Journal 18:119-42.
157. Ullrich, Axel. 2006. "Molecular Biologist at UCSF and Genentech." Oral history conducted in 1994 and 2003 by Sally Smith Hughes, Regional Oral History Office, The Bancroft Library, University of California-Berkeley.
158. Van Brunt, Jennifer. 2000. "Biotech's Impeccable Lineage." Signals, March 22.
159. Vaughan, Roger. 2000. Listen to the Music: The Life of Hilary Koprowski. New York: Springer-Verlag.
160. Vettel, Eric J. 2006. Biotech: The Countercultural Origins of an Industry. Philadelphia: University of Pennsylvania Press.
161. Weintraub, Arlene. 2009. "Can Roche Leave Genentech Alone?" Business Week, December 7, pp. 48-49.
162. White, Harrison C. 2008. Identity and Control. 2nd ed. Princeton: Princeton University Press.
163. Wilke, John. 1987. "Genzyme Says It Has a Potential Hot Seller." Boston Globe, January 6.
164. Wilson, Duff, and David Heath. 2001. "They Call the Place 'Mother Hutch.'" Seattle Times, March 14.
165. Wright, Susan. 1994. Molecular Politics. Chicago: University of Chicago Press.
166. Yi, Doogab. 2008. "Cancer, Viruses, and Mass Migration: Paul Berg's Venture into Eukaryotic Biology and the Advent of Recombinant DNA Research and Technology, 1967-1980." Journal of the History of Biology 41:589-636.
167. Yoxen, Edward. 1984. The Gene Business: Who Should Control Biotechnology? New York: Harper and Row.
168. Zaffaroni, Alejandro. 1997. "An Interview with Alejandro Zaffaroni." By J. Wolfson and T. Singh. San Jose Mercury News, February 2, 1997. Available at http://www.thetech.org/exhibits/online/revolution/zaffaroni/.
169. Zucker, Lynne G., and Michael R. Darby. 1996. "Star Scientists and Institutional Transformation: Patterns of Invention and Innovation in the Formation of the Biotechnology Industry." Proceedings of the National Academy of Sciences 93:12709-16.
170. Zucker, Lynne G., and Michael R. Darby. 1997. "Present at the Revolution: Transformation of Technical Identity for a Large Incumbent Pharmaceutical Firm after the Biotechnological Breakthrough." Research Policy 26:429-46.
171. Zuckerman, Ezra W. 1999. "The Categorical Imperative: Securities Analysts and the Illegitimacy Discount." American Journal of Sociology 104: 1398-1438.